Market Overview

Halozyme Therapeutics, Inc. (NASDAQ: HALO)

19.23 -1.04 (-5.13%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/25/20BarclaysMaintainsEqual-Weight20.0
2/25/20JP MorganMaintainsOverweight22.0
2/05/20Piper SandlerUpgradesOverweight27.0
1/27/20Cantor FitzgeraldMaintainsOverweight35.0
1/09/20BMO CapitalUpgradesOutperform24.0
1/08/20Goldman SachsInitiates Coverage OnBuy24.0
11/20/19Cantor FitzgeraldReiteratesOverweight27.0
11/13/19BMO CapitalMaintainsMarket Perform17.0
11/13/19JP MorganMaintainsOverweight23.0
11/05/19BarclaysUpgradesEqual-Weight16.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter